https://www.pharmaceutical-technology.com/ The leading site for news and procurement in the pharmaceutical industry Fri, 05 Jan 2024 18:16:16 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png https://www.pharmaceutical-technology.com/ 32 32 https://www.pharmaceutical-technology.com/news/signal-uk-online-pharmacies-selling-prescription-drugs-without-proper-checks/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Benzos.jpg Fri, 05 Jan 2024 18:15:59 +0000 https://www.pharmaceutical-technology.com/news/signal-uk-online-pharmacies-selling-prescription-drugs-without-proper-checks/ https://www.pharmaceutical-technology.com/news/intellia-propels-into-2024-with-crispr-pipeline-updates/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Intellia-image.jpg Fri, 05 Jan 2024 17:03:21 +0000 https://www.pharmaceutical-technology.com/news/intellia-propels-into-2024-with-crispr-pipeline-updates/ https://www.pharmaceutical-technology.com/news/insilico-teams-up-with-menarini-for-breast-cancer-kat6-inhibitor/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/GettyImages-1394005449-e1704470999875.jpg Fri, 05 Jan 2024 16:47:02 +0000 https://www.pharmaceutical-technology.com/news/insilico-teams-up-with-menarini-for-breast-cancer-kat6-inhibitor/ https://www.pharmaceutical-technology.com/news/moma-roche-cancer-drug/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/MOMA-.jpg Fri, 05 Jan 2024 11:14:22 +0000 https://www.pharmaceutical-technology.com/news/moma-roche-cancer-drug/ https://www.pharmaceutical-technology.com/news/abbvie-umoja-therapies-cancer/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/AbbVie-.jpg Fri, 05 Jan 2024 11:09:59 +0000 https://www.pharmaceutical-technology.com/news/abbvie-umoja-therapies-cancer/ https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2023-kai/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Kai-Logo.png Fri, 05 Jan 2024 10:59:55 +0000 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2023-kai/ https://www.pharmaceutical-technology.com/news/rhythm-expands-obesity-portfolio-with-phase-ii-weight-loss-drug-for-100m/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_2159310393.jpg Fri, 05 Jan 2024 10:56:44 +0000 https://www.pharmaceutical-technology.com/?p=270888 https://www.pharmaceutical-technology.com/news/boehringer-3t-cancer-immunotherapies/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Boehringer.jpg Fri, 05 Jan 2024 08:49:20 +0000 https://www.pharmaceutical-technology.com/news/boehringer-3t-cancer-immunotherapies/ https://www.pharmaceutical-technology.com/news/avistone-drug-financing/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/laboratory-5721244_1920.jpg Fri, 05 Jan 2024 08:44:21 +0000 https://www.pharmaceutical-technology.com/news/avistone-drug-financing/ https://www.pharmaceutical-technology.com/data-insights/osteoarthritis-purecell-group-osteoarthritis-likelihood-of-approval/ https://www.pharmaceutical-technology.com/data-insights/osteoarthritis-purecell-group-osteoarthritis-likelihood-of-approval/#respond Fri, 05 Jan 2024 00:44:56 +0000 https://www.pharmaceutical-technology.com/data-insights/osteoarthritis-purecell-group-osteoarthritis-likelihood-of-approval/feed/ 0